Atoltivimab + Maftivimab + Odesivimab

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Atoltivimab atoltivimab
Maftivimab maftivimab
Odesivimab odesivimab

Brands with this exact combination

Brand	Composition & strength	Manufacturer
InmazebUS	injection Atoltivimab 241.7 mg/14.5 mL + Maftivimab 241.7 mg/14.5 mL + Odesivimab 241.7 mg/14.5 mL injection Atoltivimab 483.3 mg/14.5 mL + Maftivimab 483.3 mg/14.5 mL + Odesivimab 483.3 mg/14.5 mL	Regeneron Pharmaceuticals, Inc.
atoltivimab, maftivimab, and odesivimab-ebgnUS	241.7 mg/14.5 mL / 483.3 mg/14.5 mL	Regeneron Pharmaceuticals, Inc.

Same combination in other markets

No product with this combination is recorded in the other covered markets yet.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.